Identification, characterization, and prognosis investigation of pivotal genes shared in different stages of breast cancer.

ABSTRACT: One of the leading causes of death (20.1 per 100,000 women per year), breast cancer is the most prevalent cancer in females. Statistically, 95% of breast cancer are categorized as adenocarcinomas, and 55% of all patients may go into invasive phases; however, it can be successfully treated in approximately 70-80% of cases if diagnosed in the nascent stages. The emergence of breast tumor cells which are intensely resistant to conventional therapies, along with the high rate of metastasis occurrence, has highlighted the importance of finding novel strategies and treatments. One of the most advantageous schemes to alleviate this complication is to identify the common differentially expressed genes (DEGs) among primary and metastatic cancerous cells to use resultants for designing new therapeut

SUBMITTER: Rommasi F 

PROVIDER: S-EPMC10212935 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature